1988
DOI: 10.1021/tx00003a008
|View full text |Cite
|
Sign up to set email alerts
|

Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2,2-trichlorovinyl)-L-cysteine formed by cysteine conjugate .beta.-lyase

Abstract: The bioactivation mechanism of S-(1,2-dichlorovinyl)-L-cysteine (DCVC) and S-(1,2,2-trichlorovinyl)-L-cysteine (TCVC) was studied with cysteine conjugate beta-lyase (beta-lyase) from Salmonella typhimurium and with the pyridoxal phosphate model N-dodecylpyridoxal bromide (PL-Br) as catalysts and with GC/MS to identify the metabolites formed. PL-Br converted S-2-benzothiazolyl-L-cysteine to 2-mercaptobenzothiazole and S-benzyl-L-cysteine to benzyl mercaptan, demonstrating the ability of PL-Br to serve as a mode… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
49
0

Year Published

1990
1990
2015
2015

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 97 publications
(50 citation statements)
references
References 13 publications
1
49
0
Order By: Relevance
“…1) that readily loses chloride ion to form dichlorothioketene. Formation of dichlorothioketene has been implicated in TETRA-induced nephrotoxicity and nephrocarcinogenicity, because of its reactivity toward renal macromolecules (Dekant et al, 1988;Vamvakas et al, 1989a,b;Pä hler et al, 1999). In the second metabolic reaction, TCVC is oxidized by flavin-containing monooxygenases (FMOs) or cytochromes P450 to form S-(1,2,2-trichlorovinyl)-L-cysteine sulfoxide (TCVCS) (Ripp et al, 1997).…”
mentioning
confidence: 99%
“…1) that readily loses chloride ion to form dichlorothioketene. Formation of dichlorothioketene has been implicated in TETRA-induced nephrotoxicity and nephrocarcinogenicity, because of its reactivity toward renal macromolecules (Dekant et al, 1988;Vamvakas et al, 1989a,b;Pä hler et al, 1999). In the second metabolic reaction, TCVC is oxidized by flavin-containing monooxygenases (FMOs) or cytochromes P450 to form S-(1,2,2-trichlorovinyl)-L-cysteine sulfoxide (TCVCS) (Ripp et al, 1997).…”
mentioning
confidence: 99%
“…Elfarra et al 40) demonstrated that intraperitoneal administration of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine to male F344 rats induced nephropathy, indicating a crucial role of the renal γ-glutamyltranspeptidase and cysteine conjugate β-lyase in the trichloroethylene-induced nephropathy. Dekant et al 41,42) reported that N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine was identified as a urinary metabolite of trichloroethylene, and that thioacylating metabolites of S-(1,2-dichlorovinyl)-L-cysteine, which were formed by renal cysteine conjugate β-lyase, might contribute to the nephrotoxic and mutagenic effects. Our previous study 43) demonstrated that DCNB was metabolized and excreted into urine as N-acetyl-S-(4-chloro-3-nitrophenyl)-L-cysteine, suggesting that DCNB was metabolized to the glutathione conjugate in the liver, subsequently to S-(4-chloro-3-nitrophenyl)-L-cysteine in the kidney.…”
Section: Carcinogenicitymentioning
confidence: 99%
“…The bioactivation of DCVC to a reactive and mutagenic thioacylating intermediate is performed by cysteine conjugate I-lyase in the kidney (133). Although similar P-lyase activity has been measured in the kidney and liver, the two enzymes are distinct (134).…”
Section: Metabolism Oftcementioning
confidence: 99%